Department of Radiology, The Alfred Hospital, Victoria, Australia.
Department of Radiology, Alfred hospital, Melbourne, Australia;Department of Surgery, Monash University, Clayton, Australia.
Diagn Interv Radiol. 2020 Sep;26(5):488-491. doi: 10.5152/dir.2020.19417.
We aimed to discuss and evaluate the technical success and efficacy of the ArtVentive endoluminal occlusion system (EOS) device for splenic embolization. A retrospective review was undertaken for all patients in whom the EOS device was deployed for the purpose of splenic embolization. Data was collected by a search of splenic artery embolization procedures in the hospital computer database. Data was reviewed for all patients in whom an EOS plug was deployed. Patient demographics, technical aspects of the procedure and follow-up at one month were reviewed. We review the technical success and efficacy of this occlusion device. Six patients underwent splenic embolization with the EOS plug. There were 5 male and 1 female patients; age range was 24-88 years. Five 8 mm and one 5 mm EOS plugs were deployed for the occlusion of the splenic artery. The technical success rate was 100% occurring in all 6 splenic arteries. One patient underwent a second angiogram and subsequent splenectomy for persistent splenic hemorrhage. One patient had a subsequent splenectomy for bacteremia with the spleen as the suspected source. This early data supports the efficacy of the EOS plug for the embolization of the proximal splenic artery.
我们旨在讨论和评估 ArtVentive 腔内闭塞系统(EOS)设备用于脾栓塞的技术成功和疗效。对所有因脾栓塞而使用 EOS 设备的患者进行了回顾性研究。通过在医院计算机数据库中搜索脾动脉栓塞术来收集数据。对所有部署 EOS 塞的患者进行了数据回顾。回顾了患者的人口统计学资料、手术的技术方面以及一个月时的随访情况。我们回顾了这种闭塞装置的技术成功和疗效。6 例患者接受了 EOS 塞的脾栓塞治疗。患者为 5 男 1 女;年龄范围为 24-88 岁。5 个 8mm 和 1 个 5mm 的 EOS 塞用于闭塞脾动脉。6 条脾动脉的技术成功率均为 100%。1 例患者因持续性脾出血行第二次血管造影和随后的脾切除术。1 例患者因菌血症且脾脏为可疑来源而行随后的脾切除术。这些早期数据支持 EOS 塞用于近端脾动脉栓塞的疗效。